SCHEMBL4659800

SCHEMBL4659800

CCCCC(CN(O)C=O)C(=O)N1CCC[C@H]1C(=O)N(C)C

nearest known ligand 0.60

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.38
REN P00797 1/20 0.38
ACE P12821 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5499080 0.89 ACE (0.50) RENACE
SCHEMBL1734898 0.88 DPP4 (0.40) RENACE
SCHEMBL12253005 0.84 DPP4 (0.40)
SCHEMBL4956515 0.82 POLB (0.41)
SCHEMBL4956518 0.82 POLB (0.41)
SCHEMBL6135700 0.81 DPP7 (0.39)
SCHEMBL6135698 0.81 DPP7 (0.39)
SCHEMBL4600121 0.79
SCHEMBL2210117 0.79 NPSR1 (0.36)
SCHEMBL4600126 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1542968-B1 PROCESS FOR PREPARING INTERMEDIATES NOVARTIS AG (CH) 2008-12-17 EP disclosed
US-7323448-B2 Antibacterial agents BRITISH BIOTECH PHARMACEUTICALS LTD. (GB) 2008-01-29 US disclosed
US-7323448-B2 Antibacterial agents BRITISH BIOTECH PHARMACEUTICALS LTD. (GB) 2008-01-29 US disclosed